Serenity
SERENITY: Evaluating the Effectiveness of Atypical Antipsychotics in the Community - a Prospective, Multicentre, Observational Study to Evaluate the Impact on Quality of Life of GP-Bases Management of Antipsychotic Treatment in Belgium.
Sponsor study identifier
observational
250
1 country
57
Study Start
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
June 2008
Actual (reported)Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on Quality of Life of GP-based management of antipsychotic treatment in Belgium
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
October 11, 2007
Actual (reported)October 12, 2007
Actual (reported)June 2008
Actual (reported)to evaluate the patient's functioning, by measuring the Quality of Life. Quality of Life will be assessed by the Q-LES-Q-16 (PRO).
The clinical efficacy & tolerability of atypical antipsychotics as assessed by the Clinical Global Impression(CGI) & Patient Global Impression of Change(PGIC)scores.
The wellbeing of the patients taking atypical antipsychotics as assessed by the Sheehan Disability Scale(SDS)
Contact the study team to confirm eligibility.
Research Site
Baudour, Belgium
Research Site
Beyne-Heysay, Belgium
Research Site
Bomal, Belgium
Research Site
Bredene, Belgium
Research Site
Brussels, Belgium
Research Site
Esen, Belgium
Research Site
Evere, Belgium
Research Site
Pitchot W Pr
ULg
First Submitted
October 11, 2007
First Posted
October 12, 2007
Study Start
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
June 2008
Actual (reported)IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
Gingelom, Belgium
Research Site
Gouy-lez-Piéton, Belgium
Research Site
Grâce-Hollogne, Belgium
Research Site
Gullegem, Belgium
Research Site
Harelbeke, Belgium
Research Site
Harre, Belgium
Research Site
Hotton, Belgium
Research Site
Houtvenne, Belgium
Research Site
Incourt, Belgium
Research Site
Ixelles-Elsene, Belgium
Research Site
Jalhay, Belgium
Research Site
Jette, Belgium
Research Site
Keumiée, Belgium
Research Site
Lembeke, Belgium
Research Site
Liège, Belgium
Research Site
Limbourg, Belgium
Research Site
Longueville, Belgium
Research Site
Lovendegem, Belgium
Research Site
Malmedy, Belgium
Research Site
Mechelen, Belgium
Research Site
Monceau-sur-Sambre, Belgium
Research Site
Montignies-sur-Sambre, Belgium
Research Site
Moorsel, Belgium
Research Site
Moorseled, Belgium
Research Site
Mouscron, Belgium
Research Site
Namur, Belgium
Research Site
Oostrozebeke, Belgium
Research Site
Ostend, Belgium
Research Site
Oudenaarde, Belgium
Research Site
Poperinge, Belgium
Research Site
Ransart, Belgium
Research Site
Roux, Belgium
Research Site
Ruisbroek, Belgium
Research Site
Schaarbeek, Belgium
Research Site
Spa, Belgium
Research Site
Staden, Belgium
Research Site
Theux, Belgium
Research Site
Tilleur, Belgium
Research Site
Torhout, Belgium
Research Site
Tubize, Belgium
Research Site
Verviers, Belgium
Research Site
Veurne, Belgium
Research Site
Wachtebeke, Belgium
Research Site
Willebroek, Belgium
Research Site
Wilrijk, Belgium
Research Site
Woluwe-St-Lambert, Belgium
Research Site
Zeebrugge, Belgium
Research Site
Zichem, Belgium
Research Site
Zomergem, Belgium
Research Site
Zonnebeke, Belgium
Last Updated
April 23, 2009
Record last verified: 2009-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: